TABLE 1.
ω-CTX-G
|
ω-CTX-M
|
|||||||
---|---|---|---|---|---|---|---|---|
Treatment Effect | Post Hoc Analysis at Dose
|
Treatment Effect | Post Hoc Analysis at Dose
|
|||||
0.005 nmol | 0.05 nmol | 0.5 nmol | 0.05 nmol | 0.15 nmol | 0.5 nmol | |||
AD threshold | 0.002 | N.S. | <0.05 | <0.05 | 0.015 | N.S. | <0.05 | <0.05 |
AD duration | 0.003 | N.S. | NS | <0.05 | 0.028 | N.S. | <0.05 | N.S. |
Seizure stage | N.S. | N.S. | ||||||
Duration of behavioral seizure | 0.041 | N.S. | N.S. | <0.05 | 0.004 | N.S. | <0.05 | N.S. |
N.S., statistically insignificant (p > 0.05).